Annual report pursuant to Section 13 and 15(d)

Marketable Securities (Details Narrative)

v3.7.0.1
Marketable Securities (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Oct. 31, 2014
Jun. 30, 2014
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Sep. 29, 2014
Jan. 31, 2014
Common stock issued     714,031,255       694,396,000       714,031,255 694,396,000      
Net loss     $ (65,754) $ (1,881) $ (3,227) $ (4,012) $ (30,449) $ (508) $ (2,623) $ (16,542) $ (74,874) $ (50,122) $ (99)    
Common stock per share     $ 0.001       $ .001       $ 0.001 $ .001      
MusclePharm, Inc [Member]                              
Common stock owned                         260,000    
Common stock issued                         600,000    
Sales held in escrow   $ 5,400                          
Shares agreed to release                           90,000  
Shares exchanged in escrow 260,000                           600,000
Net loss                     $ 1,686   $ 584    
Repurchase of common stock 250,000                            
Common stock per share $ 10.00